Prognostic factors in glioblastoma multiforme. 10 Years experience of a single institution

Strahlentherapie und Onkologie

Volumn 177, Issue 6, 2001, Pages 283-290

  Hulshof, Maarten C C M ^a   Koot, Radboud W ^a   Schimmel, Eric C ^a   Dekker, Fido ^a   Bosch, D Andries ^a   González González, Dionisio ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Glioblastoma multiforme; Prognostic factors; Radiotherapy

Indexed keywords

IRIDIUM 192;

ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; PROGNOSIS; RADIATION DOSE; TUMOR VOLUME;

EID: 0034995051     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00002409     Document Type: Article

References (28)

1. A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme
2. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma Trials
3. Selection bias, survival, and brachytherapy for glioma
4. Prognostic factors for glioblastoma multiforme. Development of a prognostic index
5. Hypofractionation in glioblastoma multiforme
6. The linear-quadratic approach to fractionation and calculation of isoeffect relationships
7. Stellenwert der radiochirurgie in der primärtherapie des glioblastoma multiforme
8. A randomized trial on dose-response in radiotherapy of low-grade cerebral glioma: European organization for research and treatment of cancer (EORTC) study 22844
9. Short course radiotherapy is an appropriate option for most malignant glioma patients
10. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas
11. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: A prospective multicenter trial of the Scandinavian Glioblastoma Study G roup
12. Radiotherapy of glioblastoma multiforme. Feasibility of increased fraction size and shortened overall treatment
13. Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma
14. Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution
15. The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults
16. A review of current and future treatment strategies for malignant astrocytomas in adults
17. A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grade 3 and/or 4
18. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: Prognostic factors and long-term outcome
19. A randomized trial of interstitial radiotherapy (IRT) boost for the treatment of newly diagnosed malignant glioma: Brain tumor co-operative group (BTCG) trial 8701
20. Hypofractionated radiation therapy in patients with glioblastoma multiforme: Results of treatment an impact of prognosic factors
21. Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boost
22. Corpus callosum involvement as a prognostic factor for patients with high grade astrocytoma
23. Fractionated Ir-192-afterloading therapy in brain tumors
24. Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma
25. Efficacy of radiotherapy for malignant gliomas in elderly patients
26. Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas
27. A randomized comparison of radiotherapy and nitrosureas for the treatment of malignant glioma after surgery
28. The prognostic importance of tumor size in malignant gliomas: A computed tomographic scan study by the brain tumor cooperative group